“Organ Preservation Market Review 2025-2033: Technological Advancements & Clinical Impact”
According to FutureWise analysis, the Organ Preservation market in Europe in 2025 is US$224.7 million and is expected to reach US$462.9 million by 2033, at a CAGR of 9.45%. The Organ Preservation market is experiencing significant growth, driven by the increasing incidence of organ failure and a rising demand for organ transplantation. Key advancements in preservation techniques, such as hypothermic and normothermic perfusion, are also contributing to this expansion. Additionally, heightened investments in healthcare infrastructure and collaborative research efforts among European countries are promoting the adoption of innovative organ preservation solutions. This trend is further strengthening the regional Organ Preservation market. The market's growth is supported by a higher incidence of organ failure, an increase in organ transplant procedures, and advancements in preservation methods, including hypothermic and normothermic machine perfusion. Supportive government initiatives and growing awareness among healthcare providers are also playing a significant role in accelerating the adoption of these practices in the region.
Technological and Product Innovations: Development of portable preservation systems with temperature control, pressure monitoring, and digital tracking for transporting organs over long distances. Introduction of improved preservation solutions that offer greater stability and extended cold-storage capabilities, aimed at optimizing the quality of organs before transplantation. Organ preservation is the process of keeping an organ viable until it can be transplanted into a recipient. This involves cooling the organ to slow down its metabolic processes and using a preservation solution to prevent tissue damage. The primary goal of organ preservation is to maintain the organ's function and viability, ensuring a successful transplantation. Effective organ preservation enables the transportation of organs over long distances, reducing the time between procurement and transplantation, which is a crucial component of the organ transplantation procedure.
Organ disease is a significant public health concern, and organ transplantation is a potentially life-saving procedure. Chronic kidney disease (CKD) causes damage to the kidneys, which may make them less effective in removing waste products from the blood over time. For example, according to information made public on World Kidney Day, a joint project of the International Federation of Kidney Foundations and the International Society of Nephrology, renal disease afflicted almost 850 million people worldwide in 2020. Estimates indicate that one in ten persons suffers from chronic kidney disease. By 2040, it is expected that CKD will account for the fifth-highest proportion of all causes of years lost to mortality worldwide. Therefore, a rise in organ illnesses may cause organ failure, necessitating transplantation and, consequently, a rise in need for organ preservation.
FutureWise Market Research has released a report that provides an in-depth analysis of Organ Preservation Market trends that shall affect the overall market growth.
Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=5768&type=requestsample
By Solution
- University of Wisconsin (UW)
- Custodial HTK
- Perfadex
- Others (Celsior & Euro-Collins)
By Technique
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
By Organ Type
- Kidneys
- Liver
- Lung
- Heart
- Others (Intestine & Pancreas)
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Organ Preservation Market:
- Bristol-myers Squibb
- Xvivo Perfusion AB
- Paragonix Technologies
- Franz Kohler Chemie Gmbh
- Biolife Solutions Inc.
- Claris Lifesciences Limited
- Lifeline Scientific
- Tolerotech Inc.
- 21st Century Medicine
- Cryolife Inc.
Recent developments by key players in the Organ Preservation Market:
Paragonix Technologies
- Acquired by Getinge (Aug 2024): Paragonix agreed to be acquired by Getinge, expanding Getinge’s global reach in solid organ transplant technologies.
- Launched a nationwide organ courier service alongside NORA in August 2024, enabling organs to be transported via commercial flights, reducing costs and emissions
- As of March 2025, their devices had been used in over 10,000 transplant cases across more than 150 centers globally.
Xvivo Perfusion AB
- Strategic partnership: In January 2024, XVIVO partnered with Getinge to integrate their lung perfusion systems with advanced life-support and monitoring platforms, co-developing AI monitoring for perfusion in Europe and North America.
- Milestone clinical use: The UK’s first double-lung transplant using XVIVO’s XPS ex-vivo perfusion system was performed at Royal Papworth Hospital in December 2024, reviving and prolonging lung viability before transplant
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=5768&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Organ Preservation Market By Solution, By Technique, By Organ Type and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
